EVALUATION OF VATERIA INDICA MODIFIED GUM AS A RELEASE RETARDANT MATRIX IN THE TABLET DOSAGE FORM

Authors

  • TUSHAR D. FEGADE Department of Pharmaceutics, Tapi Valley Education Society’s Hon’ble Loksevak Madhukarrao Chaudhari College of Pharmacy, Faizpur 425503, (M. S.), India https://orcid.org/0009-0001-6167-838X
  • VIJAY R. PATIL Department of Pharmaceutics, Tapi Valley Education Society’s Hon’ble Loksevak Madhukarrao Chaudhari College of Pharmacy, Faizpur 425503, (M. S.), India https://orcid.org/0009-0002-9297-1519
  • TUSHAR A. DESHMUKH Department of Pharmacognosy, Shellino Education Society’s Arunamai College of Pharmacy Mamurabad, Jalgaon 425001, (M. S.), India https://orcid.org/0009-0006-5696-9293

DOI:

https://doi.org/10.22159/ijpps.2023v15i4.47329

Keywords:

Vateria indica, Matrix tablet, Modified gum, Diclofenac potassium, Sustained release

Abstract

Objective: A natural gum from Vateria indica was investigated as a novel matrix-forming material for sustained drug delivery using diclofenac potassium as a model drug.

Methods: In the current investigation, we formulated a matrix tablet using chloroform soluble gum portion of Vateria indica modified gum (VIMG) as a natural matrix-forming agent. It was used with a drug-polymer ratio ranging from 1:0.5 to 1:4.5. The pre-compression study of the powder blends was done by calculating bulk density, tapped density, angle of repose, and carr’s index, compressibility, and hausner’s ratio. The tablets were prepared by direct compression method and prepared tablets were evaluated and were found according to the official guidelines by pharmacopeia. The in vitro drug release was carried out using USP paddle type II apparatus and the release was found to be sustained.

Results: The formulation VIMG-5 containing drug: polymer ratio 1:2.5 showed the 96.26%±1.73 drug release in 12 h. The results showed that chloroform soluble fraction of Vateria indica can be used as a drug release modifier to delay the rate of drug release, which depended on the amount of gum composition, as the concentration of gum was increased, there was sustained the drug release with promising accelerated stability.

Conclusion: The evaluation studies on sustained release matrix tablets using Vateria indica chloroform soluble portion of gum as natural material demonstrate the multivariate applications such as matrix forming, binder, and release retardant of the gum in tablet formulation.

Downloads

Download data is not yet available.

References

Gayathri R, Ganapathy RS. Preliminary characterization and in vitro cytotoxic studies of the polysaccharide from Araucaria heterophylla. I J Rec Sci Rese. 2017 May 28;8(5):17200-3.

Deb A, Das B. Isolation, purification and characterization of natural polymer obtained from plant Baheda (Terminalia balearica), W J Pharmacy and Pharmac Sciences. J Pharm Pharm Sci. 2016 May 9;5(6):1118-29. doi: 10.20959/wjpps20166-6868.

Deb A, Barua S, Das B. Pharmacological activities of Baheda (Terminalia balearica), a review. J Pharmacogn Phytochem. 2015 Dec 14;4(4):1-4.

Rahim H, Khan MA, Sadiq A, Khan S, Chishti KA, Rahman IU. Comparative studies of binding potential of Prunus armeniaca and Prunus domestica gums in tablets formulations. Pak J Pharm Sci. 2015;28(3):909-14. PMID 26004724.

Das B, Dash S, Choudhury RC, Chakraborty J, Deb RS. Optimization and characterization of purified polysaccharide from Terminalia belarica gum as a pharmaceutical excipient. I J of pharma res and allied Sci. 2014;3(1):21-9.

Panta S, Malviya R, Sharma P. Extraction and characterization of Boswellia serrata gum as pharmaceutical Excipient. Polim Med. 2015 Feb 3;45(1):25-30. PMID 26630726.

Deekasha MR, Sharma P. Extraction and characterization of Aeglemarmelaos derived polymer as a pharmaceutical excipient. Polymer Med. 2014 Aug 1;44(3):142-6.

Farooq U, Malviya R, Sharma PK. Extraction and characterization of Artocarpus integer gum as pharmaceutical excipient. Polim Med. 2014 Apr 23;44(2):69-74. PMID 24967778.

Arora G, Malik K, Singh I, Arora S, Rana V. Formulation and evaluation of controlled release matrix mucoadhesive tablets of domperidone using Salvia plebeian gum. J Adv Pharm Technol Res. 2011;2(3):163-9. doi: 10.4103/2231-4040.85534, PMID 22171313, PMCID 3217707.

Arora G, Malik K, Singh I. Formulation and evaluation of mucoadhesive matrix tablets of taro gum: optimization using response surface methodology. Polim Med. 2011 Jun 6;41(2):23-34. PMID 21866794.

Salsa T, Veiga F, Pina ME. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm. 1997 Jan;23(9):929-38. doi: 10.3109/03639049709148697.

Bugade D, Khan S, VateriaIndica L. A review on morphology, phytochemistry and pharmacological aspects. Int Res J Mod Eng Tech Sci. 2022 Mar;4(3):557-60.

Shrijani JK, Hegde K, Shabaraya AA. Review on pharmacological activities of Vateria indica L. Linn. Int J Pharmaand Chem Res. 2018 Mar;4(1):1-8.

Gayathri R, Ganapathy RS. Extraction and characterization of the gum isolated from Araucaria heterophylla. Int J Recent Sci Res. 2018 Mar 1;9(3):1062-7.

Government of India. Indian pharmacopoeia. The controller of publication. Vol. III. Ghaziabad: Ministry of Health and Family Welfare. Indian Pharmacopoeia Commission; 2010. p. 746-58.

Beckett AH, Stenlake JB. Practical pharmaceutical chemistry, Part II. 4th ed. New Delhi: CBS Publisher and Distributors; 2004. p. 199-205.

Sinko PJ. Martin’s physical pharmacy. 5th ed. New Delhi: Wolters Kluwer Health (India) Pvt. Ltd; 2007. p. 570-1.

Nep EI, Conway BR. Characterization of Grewia gum, a potential pharmaceutical excipient. J Excipients Food Chem. 2010 May 12;1(1):30-40.

Subhryamanyam CVS. Physical pharmacy. 2nd ed, New Delhi: Vallbh Prakashan; 2000. p. 215-7.

British Pharmacopoeia. Her Majesty’s Stationey office. London, UK: British Pharmacopoeia Commission; 2007. p. 340-6.

Martin A, Patrick N, Sinko JP. Martin’s physical pharmacy and pharmaceutical sciences physical chemical and biopharmaceutical principles in the pharmaceutical sciences. Phila: Lippincott Williams & Wilkins; 2006. p. 533-60.

Government of India. Indian pharmacopoeia. Vol. II. Ghaziabad: Indian Pharmacopoeia Commission: Ministry of Health and Welfare; 2007. p. 402-4.

Lachman L, Liberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Mumbai: Varghese Publishing House; 1991. p. 88.

Shekar BC, Kiran RS. Design and evaluation of sustained-release monolithic matrix tablets of tramadol hydrochloride. IJPI’s J Pharm Cosmetol. 2010 Jan;1(1):1-11.

Wadher KJ, Kakde RB, Umekar MJ. Formulation and evaluation of a sustained-release tablets of metformin hydrochloride using hydrophilic synthetic and hydrophobic natural polymers. Indian J Pharm Sci. 2011;73(2):208-15. doi: 10.4103/0250-474x.91579. PMID 22303065.

Beckett AH, Stenlake JB. Practical pharmaceutical chemistry, Part II. 4th ed. New Delhi: CBS publisher and distributors; 1997. p. 85-100.

The United States pharmacopoeia (USP/NF). Physical tests/dissolution. Rackville MD, The U.S. Pharmacopoeial Convention. Vol. 24(19); 2000. p. 1941-3.

ICH Guideline Guidelines for industry. Photostability testing of new drug substance and product. 1996;Q1B:1-25.

ICH Stability testing guidelines: stability testing of new drug substances and products. Vol. Q1A (R2). Rockville, MD: ICH Steering Committee; 2003. p. 1-70.

Yoshioka S, Stella VJ. Stability of drugs and dosage forms. New York: Kluwer Academic/Plenum Publishers; 2000. p. 139-50.

Chow SC. Statistical design and analysis of stability studies. 1st ed. New York: Imprint Chapman and Hall/CCR; 2007. p. 28.

Bajaj S, Singla D, Sakhuja N. Stability testing of pharmaceutical products. J Appl Pharm Sci. 2012 Mar 24;02(3):129-38.

Published

01-04-2023

How to Cite

FEGADE, T. D., V. R. PATIL, and T. A. DESHMUKH. “EVALUATION OF VATERIA INDICA MODIFIED GUM AS A RELEASE RETARDANT MATRIX IN THE TABLET DOSAGE FORM”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 15, no. 4, Apr. 2023, pp. 28-32, doi:10.22159/ijpps.2023v15i4.47329.

Issue

Section

Original Article(s)